Exhibit 10.1
AMENDMENT NO. 2
TO
CONSULTING SERVICES AGREEMENT
This Amendment No. 2 (“Amendment”) is entered into as of April 26, 2024 (“Effective Date”) by and between Board Advantage LLC, with an address of (“Consultant”), and Akari Therapeutics, Inc. located at 22 Boston Wharf Road, Fl 7, Boston, MA 02210 (“Akari”), and amends the Consulting Agreement dated July 17, 2023 and Amendment #1 dated September 27, 2023 between Akari and Consultant. Consultant and Akari are each referred to individually as a “Party” and together as the “Parties.” Capitalized terms shall have the meanings ascribed in the Agreement unless otherwise noted herein.
WHEREAS Akari and Consultant desire to modify the Consulting Agreement;
NOW, THEREFORE, in consideration of the promises and mutual covenants set forth herein, the Parties agree as follows:
Agreed to and accepted by:
AKARI THERAPEUTICS PLC | BOARD ADVANTAGE LLC |
By: /s/ Samir Patel | By: /s/ Wendy F. DiCicco |
Printed Name: Samir Patel | Printed Name: Wendy F. DiCicco |
Title: Board Member | Title: Interim CFO |
Date: 4/26/24 | Date: 4/26/24 |